Gritstone bio Inc at B Riley Securities Oncology Conference (Virtual) Transcript
Good morning, and good morning for folks here on the West Coast. So we'll get started with our next company in Gritstone bio, where we have with us Co-Founder, President and CEO, Andrew Allen. Thanks, Andrew, and the audience here for being part of B. Riley Oncology Conference.
This is Mayank Mamtani, one of the senior biotic analysts in the health care team. At any point during the fireside chat, feel free to email me questions at [email protected].
Andrew, maybe to get us started here at the highest level for folks who are less familiar with the Gritstone bio story, would love to hear about your differentiated vaccine platform that you've been working on across cancer and infectious diseases, and some of the development capabilities that you've kind of developed over the years, Andrew?
Thanks, Mayank. So first of all, thanks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |